Key facts
- Japan's health ministry is looking at expanding a rule that bases drug prices on international averages, Nikkei reported.
- The government's stated aim is a more inviting market for global pharmaceutical companies, according to Nikkei.
- New drug prices in Japan have traditionally been lower than in other markets, Nikkei reported.
Japan's government is considering measures that would set prices for new drugs closer to the higher levels charged in other markets, Nikkei reported on November 19, 2026. The report said the aim is to create a more inviting market for global pharmaceutical companies.
The health ministry is looking at expanding a rule that bases prices on international averages, according to Nikkei. New drug prices in Japan have traditionally been lower than in other markets, the report said.
The report gave no figure for the price gap, no timetable for a decision and no named official behind the review.
